Franklin Genomic Advancements ETF Rating $39.56 -0.17 (-0.43%) As of 09:51 AM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock Franklin Genomic Advancements ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HELX Aggregate RatingModerate Buy 2.79Holdings in HELX have an aggregate rating of Moderate Buy based on 404 analyst ratings issued in the past year covering 22 companies (70.8% of the portfolio).HELX Aggregate Price Target$39.73High Prediction$39.73Average Prediction$39.73Low Prediction$39.73Holdings in HELX have an aggregate price target of $39.73 and a range of $39.73 to $39.73 covering 22 companies (70.8% of the portfolio).HELX Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy20 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Franklin Genomic Advancements ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 HELX Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.90%GHGuardant Health$161.77+2.1%2.8181 of 5 stars2.96$158.74 -1.9%25News CoveragePositive NewsAnalyst Forecast7.47%NTRANatera$275.01+0.8%2.2085 of 5 stars2.86$267.83 -2.6%22Analyst Forecast6.21%KRYSKrystal Biotech$347.79-4.3%2.6297 of 5 stars2.83$360.67 3.7%12Positive NewsAnalyst Forecast4.55%LGNDLigand Pharmaceuticals$302.15-2.3%2.7174 of 5 stars2.88$292.86 -3.1%8Positive News3.83%ADPTAdaptive Biotechnologies$21.20+0.9%1.7608 of 5 stars2.57$20.83 -1.7%73.53%BBIOBridgeBio Pharma$82.47-0.7%3.1742 of 5 stars2.83$94.63 14.7%23Trending NewsAnalyst ForecastInsider TradeAnalyst RevisionGap Up3.50%UTHRUnited Therapeutics$529.13-1.2%4.5112 of 5 stars2.83$644.82 21.9%12Insider TradeGap Down2.91%LLYEli Lilly and Company$1,150.09-2.7%4.5068 of 5 stars2.87$1,271.93 10.6%30Trending NewsAnalyst Forecast2.84%VRTXVertex Pharmaceuticals$478.17-0.4%3.9182 of 5 stars2.84$559.61 17.0%25Analyst Forecast2.67%TWSTTwist Bioscience$93.38+3.4%1.7614 of 5 stars2.70$87.30 -6.5%10Analyst ForecastInsider Trade2.53%TVTXTravere Therapeutics$56.76+0.8%2.2155 of 5 stars2.69$52.08 -8.2%13Positive News2.48%INSMInsmed$108.21-0.9%4.1121 of 5 stars2.96$211.00 95.0%252.22%CTVACorteva$85.54-0.6%3.0324 of 5 stars2.59$88.95 4.0%22Analyst Forecast2.20%MEDPMedpace$534.37+0.8%1.9955 of 5 stars2.07$469.50 -12.1%15News CoverageAnalyst Forecast1.98%ALNYAlnylam Pharmaceuticals$280.15-2.7%4.1147 of 5 stars2.85$455.31 62.5%26Analyst Forecast1.97%TEMTempus AI$57.12+2.1%3.2173 of 5 stars2.47$68.54 20.0%151.92%IONSIonis Pharmaceuticals$55.31-2.5%3.5866 of 5 stars2.81$96.05 73.7%21Trending NewsAnalyst ForecastAnalyst Revision1.86%NBIXNeurocrine Biosciences$170.92-1.8%4.5901 of 5 stars2.96$191.67 12.1%23Trending NewsAnalyst ForecastInsider Trade1.83%REGNRegeneron Pharmaceuticals$658.26-0.7%4.6679 of 5 stars2.70$787.67 19.7%271.55%VCYTVeracyte$56.69-1.4%2.8823 of 5 stars2.78$54.43 -4.0%9Positive NewsAnalyst Upgrade1.45%PTCTPTC Therapeutics$79.81-1.9%3.0059 of 5 stars2.80$91.57 14.7%15News CoverageInsider Trade1.41%BNTXBioNTech$90.11+0.0%4.5379 of 5 stars2.74$129.13 43.3%19Positive News This page (BATS:HELX) was last updated on 7/14/2026 by MarketBeat.com Staff. From Our PartnersMan who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...Paradigm Press | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredThey told you not to miss this oneThe largest companies in the SP 500 are now more overvalued relative to fundamentals than they were at the abs...Thor Metals | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...American Alternative | SponsoredAmerican’s Biggest Threat Is HereThis feels like one of those ''where were you when Kennedy was shot'' moments. It felt like a moment in time, ...Goldco Direct, LLC | SponsoredThey proved it worked in '76. Then buried it.In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...Behind the Markets | SponsoredThis Is How Financial Freedom Dies—And Most People Never See It ComingWhile the trade war grabs headlines, the Department of Justice has quietly argued in court that cash may not b...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Franklin Genomic Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Franklin Genomic Advancements ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HELX Stock Alerts